Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy

被引：1
|
作者：
Garoutte, Camille
Poulet, Claire
Obstler, Jean Baptiste
Bourgeois, Anne-Marie
Khamis, Warda
Dewolf, Maxime
Faouzi, Sara
Galmiche, Antoine
Jounieaux, Vincent
Andrejak, Claire
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Biomarkers; Lung cancer / Oncology; Infections;
D O I：
10.1183/13993003.congress-2016.PA2822
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2822
引用
收藏
页数：1
相关论文
共 50 条
  • [31] First-Line Immunotherapy in Elderly Patients with Stage iv Non-Small Cell Lung Cancer: an Early Efficacy and Safety Assessment
    Kuon, Jonas
    Blasi, Miriam
    Grosch, Heidrun
    Christopoulos, Petros
    Wiedemann, Christiane
    Herth, Felix
    Heussel, Claus-Peter
    Stenzinger, Albrecht
    Thomas, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 118 - 119
  • [32] Impact of next generation sequencing on a clinicians' first line treatment decision in patients with stage IV non-small cell lung cancer
    Megahed, Ahmed
    Zheng, Dominick
    Chen, Lie H.
    Haque, Reina
    McGary, Eric C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] DIAGNOSTIC AND PROGNOSTIC IMPACT OF SERUM PROCALCITONIN IN NON-SMALL CELL LUNG CANCER
    Kajikawa, Shigehisa
    Oohasi, Wataru
    Yonezawa, Toshiyuki
    Kosaka, Kenji
    Matsubara, Ayako
    Kato, Toshio
    Tanaka, Hiroyuki
    Ito, Satoru
    Yamaguchi, Etsuro
    Kubo, Akihito
    RESPIROLOGY, 2019, 24 : 52 - 52
  • [34] Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
    Chhatre, Sumedha
    Vachani, Anil
    Allison, Ron R.
    Jayadevappa, Ravishankar
    CANCERS, 2021, 13 (04) : 1 - 11
  • [35] The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer
    Elmushraf, R.
    Clinch, H.
    Salawu, A.
    Fisher, P.
    Young, R.
    Lee, C.
    Danson, S.
    Bates, E.
    Hatton, M.
    Low, L.
    Das, T.
    Taylor, F.
    LUNG CANCER, 2019, 127 : S43 - S43
  • [36] A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer
    Blakely, L.
    Schwartzberg, L. S.
    Schnell, F. M.
    Sabbath, K. D.
    Miller, P. J.
    Stepanski, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer - experience from a prematurely closed phase II study
    Raez, LE
    Rosado, MF
    Santos, ES
    Reis, IM
    LUNG CANCER, 2004, 45 (01) : 131 - 132
  • [38] Serum autoantibodies as prognostic biomarkers for stage IV non-small cell lung cancer (NSCLC).
    Pergande, Melissa R.
    Piper, Clinton T.
    Fhied, Cristina L.
    Mahon, Brett
    Fidler, Mary J.
    Bonomi, Philip
    Borgia, Jeffrey Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [40] Modern treatment approaches for patients with IV stage of non-small cell lung cancer
    Kadzhoyan, A. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2013, (03) : 79 - 83
12345